TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 SEK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover | 780 | 483 | |
Financial expenses | 426 | 4 | |
Earnings before taxes | 69 | -90 | |
EBITDA | 484 | -110 | |
Total assets | 15,144 | 15,273 | |
Current assets | 935 | 698 | |
Current liabilities | 271 | 165 | |
Equity capital | 14,754 | 14,974 | |
- share capital | 100 | 100 | |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency | 97.4% | 98.0% | |
Turnover per employee | 780 | 483 | |
Profit as a percentage of turnover | 8.8% | -18.6% | |
Return on assets (ROA) | 3.3% | -0.6% | |
Current ratio | 345.0% | 423.0% | |
Return on equity (ROE) | 0.5% | -0.6% | |
Change turnover | 297 | -120 | |
Change turnover % | 62% | 61% | -20% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.